News | July 07, 2023
Alkem forays into ophthalmology with launch of eye care products
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
PEEK brings a new quality to dental care for patients
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)
Subscribe To Our Newsletter & Stay Updated
